Loading...
XNYS
AFL
Market cap57bUSD
Apr 10, Last price  
106.81USD
1D
-0.59%
1Q
3.65%
Jan 2017
200.80%
Name

Aflac Inc

Chart & Performance

D1W1MN
P/E
10.71
P/S
3.05
EPS
9.97
Div Yield, %
1.43%
Shrs. gr., 5y
-5.42%
Rev. gr., 5y
-3.03%
Revenues
19.13b
+2.28%
14,363,000,00014,616,000,00015,393,000,00016,554,000,00018,254,000,00020,732,000,00022,171,000,00025,364,000,00023,939,000,00022,728,000,00020,872,000,00022,559,000,00021,667,000,00021,758,000,00022,307,000,00022,147,000,00022,106,000,00019,140,000,00018,701,000,00019,128,000,000
Net income
5.44b
+16.83%
1,483,000,0001,483,000,0001,634,000,0001,254,000,0001,497,000,0002,344,000,0001,964,000,0002,866,000,0003,158,000,0002,951,000,0002,533,000,0002,659,000,0004,371,000,0002,920,000,0003,304,000,0004,778,000,0004,231,000,0004,418,000,0004,659,000,0005,443,000,000
CFO
2.71b
-15.14%
4,433,000,0004,397,000,0004,656,000,0004,965,000,0006,161,000,0006,989,000,00010,842,000,00014,952,000,00010,547,000,0006,550,000,0006,776,000,0005,987,000,0006,128,000,0006,014,000,0005,455,000,0005,958,000,0005,051,000,0003,879,000,0003,190,000,0002,707,000,000
Dividend
Feb 19, 20250.58 USD/sh
Earnings
Apr 29, 2025

Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care income support, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan. The Aflac U.S. segment provides cancer, accident, short-term disability, critical illness, hospital indemnity, dental, vision, long-term care and disability, and term and whole life insurance products in the United States. It sells its products through sales associates, brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies. The company was founded in 1955 and is based in Columbus, Georgia.
URL
https://www.aflac.com/
IPO date
Jun 15, 1974
Employees
12,882
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
19,128,000
2.28%
18,701,000
-2.29%
19,140,000
-13.42%
Cost of revenue
3,116,000
3,473,000
Unusual Expense (Income)
NOPBT
19,128,000
15,585,000
15,667,000
NOPBT Margin
100.00%
83.34%
81.85%
Operating Taxes
974,000
603,000
451,000
Tax Rate
5.09%
3.87%
2.88%
NOPAT
18,154,000
14,982,000
15,216,000
Net income
5,443,000
16.83%
4,659,000
5.45%
4,418,000
4.42%
Dividends
(1,087,000)
(966,000)
(979,000)
Dividend yield
1.86%
1.96%
2.13%
Proceeds from repurchase of equity
(2,786,000)
(2,784,000)
(2,384,000)
BB yield
4.77%
5.64%
5.20%
Debt
Debt current
55,000
Long-term debt
7,515,000
7,488,000
7,589,000
Deferred revenue
(6,182,000)
Other long-term liabilities
84,049,000
97,375,000
84,520,000
Net debt
3,494,000
(23,520,000)
(167,928,000)
Cash flow
Cash from operating activities
2,707,000
3,190,000
3,879,000
CAPEX
Cash from investing activities
2,781,000
817,000
(1,540,000)
Cash from financing activities
(3,486,000)
(3,723,000)
(3,551,000)
FCF
17,437,000
14,490,000
15,224,000
Balance
Cash
4,021,000
28,223,000
79,684,000
Long term investments
2,785,000
95,888,000
Excess cash
3,064,600
30,072,950
174,615,000
Stockholders' equity
49,435,000
42,609,000
38,073,000
Invested Capital
114,501,400
96,651,050
85,544,000
ROIC
17.20%
16.45%
17.56%
ROCE
16.27%
12.30%
12.07%
EV
Common stock shares outstanding
565,015
598,745
637,655
Price
103.44
25.38%
82.50
14.68%
71.94
23.21%
Market cap
58,445,152
18.32%
49,396,462
7.68%
45,872,901
16.09%
EV
61,939,152
25,876,462
(122,055,099)
EBITDA
19,128,000
15,585,000
15,712,000
EV/EBITDA
3.24
1.66
Interest
197,000
195,000
226,000
Interest/NOPBT
1.03%
1.25%
1.44%